Display options
Cite
Maisch B, Alter P, Pankuweit S. Diabetic cardiomyopathy--fact or fiction?. Herz. 2011;36(2):102-15doi: 10.1007/s00059-011-3429-4.
Maisch, B., Alter, P., & Pankuweit, S. (2011). Diabetic cardiomyopathy--fact or fiction?. Herz, 36(2), 102-15. https://doi.org/10.1007/s00059-011-3429-4
Maisch, B, et al. "Diabetic cardiomyopathy--fact or fiction?." Herz vol. 36,2 (2011): 102-15. doi: https://doi.org/10.1007/s00059-011-3429-4
Maisch B, Alter P, Pankuweit S. Diabetic cardiomyopathy--fact or fiction?. Herz. 2011 Mar;36(2):102-15. doi: 10.1007/s00059-011-3429-4. PMID: 21424347.
Copy Download .nbib Format: NLM
Share it on

Herz. 2011 Mar;36(2):102-15. doi: 10.1007/s00059-011-3429-4.

Diabetic cardiomyopathy--fact or fiction?.

Herz

B Maisch, P Alter, S Pankuweit

Affiliations

  1. Klinik für Innere Medizin-Kardiologie, UKGM GmbH und Philipps-Universität Marburg, Baldingerstr., 35043, Marburg, Deutschland. [email protected]

PMID: 21424347 DOI: 10.1007/s00059-011-3429-4

Abstract

Epidemiologic as well as clinical studies confirm the close link between diabetes mellitus and heart failure. Diabetic cardiomyopathy (DCM) is still a poorly understood "entity", however, with several contributing pathogenetic factors which lead in different stages of diabetes to characteristic clinical phenotypes. Hyperglycemia with a shift from glucose metabolism to increased beta-oxidation and consecutive free fatty acid damage (lipotoxicity) to the myocardium, insulin resistance, renin-angiotensin-aldosterone system (RAAS) activation, altered calcium homeostasis and structural changes from the natural collagen network to a stiffer matrix due to advanced glycation endproduct (AGE) formation, hypertrophy and fibrosis contribute to the respective clinical phenotypes of DCM. We propose the following classification of cardiomyopathy in diabetic patients: a) Diastolic heart failure with normal ejection fraction (HFNEF) in diabetic patients often associated with hypertrophy without relevant hypertension. Relevant coronary artery disease (CAD), valvular disease and uncontrolled hypertension are not present. This is referred to as stage 1 DCM. b) Systolic and diastolic heart failure with dilatation and reduced ejection (HFREF) in diabetic patients excluding relevant CAD, valvular disease and uncontrolled hypertension as stage 2 DCM. c) Systolic and/or diastolic heart failure in diabetic patients with small vessel disease (microvascular disease) and/or microbial infection and/or inflammation and/or hypertension but without CAD as stage 3 DCM. d) If heart failure may also be attributed to infarction or ischemia and remodeling in addition to stage 3 DCM the term should be heart failure in diabetes or stage 4 DCM. These clinical phenotypes of diabetic cardiomyopathy can be separated by biomarkers, non-invasive (echocardiography, cardiac magnetic resonance imaging) and invasive imaging methods (levocardiography, coronary angiography) and further analysed by endomyocardial biopsy for concomitant viral infection. The role of specific diabetic drivers to the clinical phenotypes, to macro- and microangiopathy as well as accompanying risk factors or confounders, e.g. hypertension, autoimmune factors or inflammation with or without viral persistence, need to be identified in each individual patient separately. Thus hyperglycemia, hyperinsulinemia and insulin resistance as well as lipotoxicity by free fatty acids (FFAs) are the factors responsible for diabetic cardiomyopathy. In stage 1 and 2 DCM diabetic cardiomyopathy is clearly a fact. However, precise determination of to what degree the various underlying pathogenetic processes are responsible for the overall heart failure phenotype remains a fiction.

References

  1. Herz. 2010 May;35(3):161-8 - PubMed
  2. Coron Artery Dis. 2001 Feb;12 Suppl 1:S29-33 - PubMed
  3. Mol Cell Biochem. 1998 Mar;180(1-2):53-7 - PubMed
  4. J Clin Pathol. 1993 Jan;46(1):32-6 - PubMed
  5. Herz. 2004 Dec;29(8):788-93 - PubMed
  6. Physiology (Bethesda). 2006 Aug;21:250-8 - PubMed
  7. Herz. 2004 Feb;29(1):17-25 - PubMed
  8. J Am Coll Cardiol. 2009 Oct 13;54(16):1524-32 - PubMed
  9. Circ Cardiovasc Imaging. 2010 Sep;3(5):507-14 - PubMed
  10. Circulation. 2000 May 16;101(19):2271-6 - PubMed
  11. Mol Cell Biochem. 2008 Jul;314(1-2):179-91 - PubMed
  12. Circulation. 1996 Mar 1;93(5):841-2 - PubMed
  13. Rheumatology (Oxford). 2006 Oct;45 Suppl 4:iv32-8 - PubMed
  14. Herz. 2006 Jun;31(4):361-5 - PubMed
  15. Lancet. 2004 Nov 13-19;364(9447):1786-8 - PubMed
  16. Herz. 2006 May;31(3):200-6 - PubMed
  17. N Engl J Med. 2007 Mar 15;356(11):1140-51 - PubMed
  18. Herz. 2010 May;35(3):140-6 - PubMed
  19. Jpn Heart J. 1988 Jul;29(4):455-63 - PubMed
  20. Eur Heart J. 2007 Jan;28(1):88-136 - PubMed
  21. Herz. 2006 May;31(3):185-8 - PubMed
  22. J Mol Cell Cardiol. 2010 Mar;48(3):524-9 - PubMed
  23. Eur Heart J. 2008 Jan;29(2):270-6 - PubMed
  24. Herz. 2006 Oct;31(7):708-14 - PubMed
  25. Circulation. 1997 Oct 7;96(7):2190-6 - PubMed
  26. Cardiovasc Res. 2000 May;46(2):324-31 - PubMed
  27. Pflugers Arch. 2008 Jan;455(4):627-36 - PubMed
  28. Heart. 2007 Dec;93(12):1571-6 - PubMed
  29. Circulation. 2007 Jun 26;115(25):3213-23 - PubMed
  30. J Am Coll Cardiol. 2006 Oct 17;48(8):1688-97 - PubMed
  31. Diabetes. 2002 Jan;51(1):174-81 - PubMed
  32. JAMA. 1979 May 11;241(19):2035-8 - PubMed
  33. J Clin Invest. 1977 Oct;60(4):884-99 - PubMed
  34. Am J Physiol Heart Circ Physiol. 2002 Jan;282(1):H138-48 - PubMed
  35. Am Heart J. 2006 Apr;151(4):829-36 - PubMed
  36. Diabetes Care. 2006 Mar;29(3):588-94 - PubMed
  37. Herz. 2006 May;31(3):260-8 - PubMed
  38. Circulation. 2000 Sep 19;102(12):1388-93 - PubMed
  39. Am J Cardiol. 2001 Jun 1;87(11):1260-5 - PubMed
  40. Circ Res. 2001 May 11;88(9):918-24 - PubMed
  41. Ann N Y Acad Sci. 2001 Apr;928:48-53 - PubMed
  42. Eur Heart J. 2004 Apr;25(7):587-610 - PubMed
  43. Am J Cardiol. 1972 Nov 8;30(6):595-602 - PubMed
  44. Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):347-60 - PubMed
  45. Diabetes Res Clin Pract. 2008 Feb;79(2):262-8 - PubMed
  46. Arch Biochem Biophys. 2003 Dec 1;420(1):176-84 - PubMed
  47. Diabetes. 2009 Jun;58(6):1373-81 - PubMed
  48. Herz. 2004 Sep;29(6):624-36 - PubMed
  49. J Cell Mol Med. 2009 Aug;13(8B):1751-1764 - PubMed
  50. Herz. 2008 Apr;33(3):223-32 - PubMed
  51. Circulation. 1992 Dec;86(6):1810-8 - PubMed
  52. J Cardiovasc Magn Reson. 2001;3(3):267-81 - PubMed
  53. Diabetes. 2006 Mar;55(3):798-805 - PubMed
  54. J Am Coll Cardiol. 2006 Feb 7;47(3):598-604 - PubMed
  55. Circulation. 2004 Aug 24;110(8):894-6 - PubMed
  56. J Biochem. 1995 Nov;118(5):1054-60 - PubMed
  57. Diabetologia. 2010 Jun;53(6):1033-45 - PubMed
  58. Internist (Berl). 2008 Apr;49(4):436-40 - PubMed
  59. Biochem Soc Trans. 1990 Dec;18(6):1125-7 - PubMed
  60. J Am Coll Cardiol. 1997 Aug;30(2):527-32 - PubMed
  61. Eur Heart J. 2008 Sep;29(18):2316 - PubMed
  62. Cardiovasc Res. 1997 Apr;34(1):34-40 - PubMed
  63. Circ Res. 1988 Mar;62(3):535-42 - PubMed
  64. Diabetes Care. 2001 Sep;24(9):1614-9 - PubMed
  65. Circulation. 2007 Sep 4;116(10):1170-5 - PubMed
  66. Am J Cardiol. 2009 Nov 15;104(10):1398-401 - PubMed
  67. Can J Physiol Pharmacol. 2007 Aug;85(8):790-9 - PubMed
  68. Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2237-45 - PubMed
  69. J Am Coll Cardiol. 2005 Sep 20;46(6):e1-82 - PubMed
  70. Endocr Rev. 2004 Aug;25(4):543-67 - PubMed
  71. Chest. 1999 Mar;115(3):867-8 - PubMed
  72. Cardiovasc Diabetol. 2007 Feb 19;6:6 - PubMed
  73. Circulation. 2007 Apr 3;115(13):1769-76 - PubMed
  74. Lancet. 1954 Feb 20;266(6808):377-9 - PubMed
  75. Diabetes. 2001 Oct;50(10):2363-75 - PubMed
  76. Circulation. 2001 Jun 5;103(22):2668-73 - PubMed
  77. Cardiovasc Res. 1998 Nov;40(2):239-47 - PubMed
  78. Rev Endocr Metab Disord. 2010 Mar;11(1):31-9 - PubMed
  79. BMJ. 2000 Aug 12;321(7258):405-12 - PubMed
  80. Diabetes Care. 2003 Oct;26(10):2791-5 - PubMed
  81. Am J Cardiol. 2004 Apr 1;93(7):870-5 - PubMed
  82. Eur Heart J. 2007 Oct;28(20):2539-50 - PubMed
  83. J Am Coll Cardiol. 1998 Feb;31(2):404-12 - PubMed
  84. Am J Cardiol. 2001 Jul 19;88(2A):70E-73E - PubMed
  85. Eur J Heart Fail. 2007 May;9(5):469-76 - PubMed
  86. Circ Cardiovasc Imaging. 2010 Jul;3(4):392-7 - PubMed
  87. Am J Med. 2008 Sep;121(9):748-57 - PubMed
  88. Diabetes Care. 2003 Aug;26(8):2433-41 - PubMed
  89. Herz. 2006 Dec;31(9):881-90 - PubMed
  90. Circulation. 2004 May 11;109(18):2191-6 - PubMed
  91. Invest Radiol. 2005 Jan;40(1):19-26 - PubMed

MeSH terms

Publication Types